Top

Notice of Intent to Sole Source – Bayer Healthcare

Active

26-007180Federal

Response Deadline07/24/2026, 09:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The National Institutes of Health Clinical Center intends to sole source a firm fixed price purchase order to Bayer Healthcare LLC for three upgrades to existing CT contrast injectors located in its Radiology and Imaging Sciences Department in Bethesda, Maryland. These upgrades are necessary to maintain FDA compliance, ensure the proper calibration of life-critical safety features, and guarantee seamless integration with the existing CT imaging systems, as the proprietary technology used in the current injectors can only be serviced by the original equipment manufacturer. The acquisition falls under Federal Acquisition Regulation Part 13 Simplified Acquisition Procedures, which permits sole source awards when only one source is reasonably available, and it is exempt from full competition requirements due to the nature of the equipment and the urgency of maintaining operational safety and regulatory standards. The contract is classified under Product Service Code 6515 and NAICS Code 339112, and the performance location is clearly designated as Bethesda, MD. This is a notice of intent, not a solicitation, and no formal request for quotations will be issued. Interested parties are invited to submit comments regarding their capabilities prior to the closing date of July 24, 2026, at 5:00 PM EST, though the government retains full discretion over whether to proceed with the sole source award based on feedback received. All submissions must reference solicitation number 26-007180 and be sent to Kristin Nagashima, Contract Specialist, at kristin.nagashima@nih.gov. The award will be made directly to Bayer Healthcare LLC, located at 100 Bayer Blvd, Whippany, NJ 07981, without competitive bidding, as the technology involved is exclusive to the manufacturer and critical for the continued safe and effective operation of diagnostic imaging services at the NIH Clinical Center.

General Info

NIH sole sources Bayer Healthcare for CT injector upgrades to ensure FDA compliance and safety in Bethesda, MD.

Agency

Department Of Health And Human Services → National Institutes Of Health - CcView Agency

NAICS

339112 - Surgical and Medical Instrument ManufacturingView NAICS

Place of Performance

MD, 20892, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 16

special-notice

Response DeadlineJul 24

Submission deadline

Response Deadline

07/24/2026, 09:00:00 PM UTCin about 8 hours

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → National Institutes Of Health - Cc

Contacts1 person available

OfficeBETHESDA, MD, 20892, USA

Organization / Agency

Department Of Health And Human Services → National Institutes Of Health - Cc

View Agency Profile

Office AddressBETHESDA, MD, 20892, USA

Contacts

Kristin Nagashima

contact@example.gov

Full Description

This acquisition is for three (3) upgrades to existing Bayer Healthcare LLC CT contrast injectors at the National Institutes of Health (NIH) Clinical Center (CC) Radiology and Imaging Sciences Department (RADIS).

• Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies

• NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing

• Place of Performance: Bethesda, MD 20892 USA

POTS: 26-007180

Description:

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.

The National Institutes of Health (NIH) intends to award a fixed price purchase order to Bayer Healthcare, LLC, located at 100 Bayer Blvd, Whippany, NJ 07981, on a firm fixed price sole source award basis to provide the required upgrades to the National Institutes of Health.

CT contrast injectors require Original Equipment Manufacturer (OEM) upgrades to maintain compliance with FDA regulations, ensure calibration of life-critical pressure-limiting safety features, and guarantee seamless software integration with the CT imaging system. The existing Bayer contrast injectors use proprietary technology and can only be upgraded by the original equipment manufacturer (i.e., Bayer HealthCare). This upgrade is required to ensure the Radiology department continues to deliver high-quality, precise contrast-enhanced CT scans.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by July 24, 2026 at 5pm EST.